OBJECTIVE The first-appearing b-cell autoantibody has been shown to influence risk of type 1 diabetes (T1D). Here, we assessed the risk of autoantibody spreading to the second-appearing autoantibody and further progression to clinical disease in The Environmental Determinants of Diabetes in the Young (TEDDY) study. RESEARCH DESIGN AND METHODS Eligible children with increased HLA-DR-DQ genetic risk for T1D were followed quarterly from age 3 months up to 15 years for development of a single first-appearing autoantibody (GAD antibody [GADA], insulin autoantibody [IAA], or insulinoma antigen-2 autoantibody [IA-2A]) and subsequent development of a single second-appearing autoantibody and progression to T1D. Autoantibody positivity was defined as...
This paper seeks to determine whether factors related to autoimmunity risk remain significant after ...
The etiology of type 1 diabetes foreshadows the pancreatic islet beta-cell autoimmune pathogenesis t...
OBJECTIVE: To distinguish among predictors of seroconversion, progression to multiple autoantibodies...
OBJECTIVE: The first-appearing β-cell autoantibody has been shown to influence risk of type 1 diabet...
AIMS/HYPOTHESIS: Young children who develop multiple autoantibodies (mAbs) are at very high risk for...
AIMS/HYPOTHESIS: Islet autoantibodies, in addition to elevated blood glucose, define type 1 diabetes...
Aims/hypothesis Islet autoantibodies, in addition to elevated blood glucose, define type 1 diabetes....
AIMS: The onset of clinical type 1 diabetes (T1D) is preceded by the occurrence of disease-specific ...
Aims: The onset of clinical type 1 diabetes (T1D) is preceded by the occurrence of disease-specific ...
OBJECTIVE β-Cell autoantibodies are a feature of the preclinical phase of type 1 diabetes. Here, we ...
AIMS/HYPOTHESIS: Progression to type 1 diabetes in children and adolescents is not uniform. Based on...
OBJECTIVE: To distinguish among predictors of seroconversion, progression to multiple autoantibodies...
OBJECTIVE: β-Cell autoantibodies are a feature of the preclinical phase of type 1 diabetes. Her...
We analyzed demographic and genetic differences between children with various diabetes-associated au...
The transition to clinical type 1 diabetes occurs between young people by creating autoantibodies to...
This paper seeks to determine whether factors related to autoimmunity risk remain significant after ...
The etiology of type 1 diabetes foreshadows the pancreatic islet beta-cell autoimmune pathogenesis t...
OBJECTIVE: To distinguish among predictors of seroconversion, progression to multiple autoantibodies...
OBJECTIVE: The first-appearing β-cell autoantibody has been shown to influence risk of type 1 diabet...
AIMS/HYPOTHESIS: Young children who develop multiple autoantibodies (mAbs) are at very high risk for...
AIMS/HYPOTHESIS: Islet autoantibodies, in addition to elevated blood glucose, define type 1 diabetes...
Aims/hypothesis Islet autoantibodies, in addition to elevated blood glucose, define type 1 diabetes....
AIMS: The onset of clinical type 1 diabetes (T1D) is preceded by the occurrence of disease-specific ...
Aims: The onset of clinical type 1 diabetes (T1D) is preceded by the occurrence of disease-specific ...
OBJECTIVE β-Cell autoantibodies are a feature of the preclinical phase of type 1 diabetes. Here, we ...
AIMS/HYPOTHESIS: Progression to type 1 diabetes in children and adolescents is not uniform. Based on...
OBJECTIVE: To distinguish among predictors of seroconversion, progression to multiple autoantibodies...
OBJECTIVE: β-Cell autoantibodies are a feature of the preclinical phase of type 1 diabetes. Her...
We analyzed demographic and genetic differences between children with various diabetes-associated au...
The transition to clinical type 1 diabetes occurs between young people by creating autoantibodies to...
This paper seeks to determine whether factors related to autoimmunity risk remain significant after ...
The etiology of type 1 diabetes foreshadows the pancreatic islet beta-cell autoimmune pathogenesis t...
OBJECTIVE: To distinguish among predictors of seroconversion, progression to multiple autoantibodies...